Nuvve (NVVE) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
27 Jun, 2026Opening remarks and agenda
Meeting called to order virtually, with all board members and CFO present to welcome shareholders and outline the agenda.
Shareholders thanked for their participation and voting, both in advance and during the meeting.
Shareholder proposals
Proposal to amend the certificate of incorporation to authorize a reverse stock split within a 1:2 to 1:40 range, with the exact ratio to be determined by the board.
Proposal to approve, for NASDAQ compliance, the issuance of 19.99% or more of outstanding shares in connection with Omnia Venture agreements, including Series B Preferred Stock conversion.
Proposal to approve adjournment of the meeting if necessary to solicit additional proxies.
Q&A with stakeholders
Shareholders invited to submit questions via the virtual platform, limited to the proposals on the agenda.
No questions were submitted regarding the proposals.
Latest events from Nuvve
- Shareholders vote on Brian Johnson and Deloitte’s FY2026 auditor appointment.NVVE
Proxy filing - Omnia milestones could shift majority voting control as stockholders vote on director and auditor matters.NVVE
Proxy filing - Revenue up 268% year-over-year, net loss narrowed 46%, and a 42 MW Romanian battery project acquired.NVVE
Q2 2026 - Revenue up 49% to $1.39M, net loss narrows, but liquidity and Nasdaq risks persist.NVVE
Q1 2026 - Special meeting adjourned for lack of quorum; reconvened for June 23, 2026, with voting ongoing.NVVE
Proxy filing - Special meeting adjourned for lack of quorum; reconvened for June 15, 2026, with voting ongoing.NVVE
Proxy filing - Key votes include a reverse stock split and Omnia-related share issuance leading to a change of control.NVVE
Proxy filing - Key votes include a reverse stock split and Omnia share issuance, both Board-recommended.NVVE
Proxy filing - Revenue and margins rose, but inventory impairment drove a higher net loss in Q4 2025.NVVE
Q4 2025